Immune cell networks key to success of personalized cancer treatment

Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a personalized immunotherapy known as adoptive T cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL).

Young mental health sufferers stuck in hospital limbo, study finds

Young people needing beds urgently for their mental health needs are waiting for long periods on acute general hospital wards, before being placed on wards

December 15, 2023

APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Biotech Investments

APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 27-Jul-2023

July 28, 2023

Twist Bioscience lays off 212 staffers, mostly in San Francisco

Twist Bioscience is laying off 212 employees, effective July 3, according to California WARN notices — with 197 of those staffers in San Francisco. The

June 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.